Related Experiment Video
Updated: Aug 11, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Haemophilus influenzae resistance in Latin America: systematic review of surveillance data
A L de Andrade1, M C Brandileone, J L Di Fabio
1Institute of Tropical Pathology and Public Health, Federal University of Goias, Brazil. ana@iptsp.ufg.br
Insights
Antimicrobial resistance in Haemophilus influenzae is a concern in Latin America. Resistance to ampicillin and trimethoprim-sulfamethoxazole (TMP-SMX) was higher in noninvasive strains, with TMP-SMX resistance increasing over time.
Area of Science:
- * Infectious Diseases
- * Microbiology
- * Public Health
Background:
- * Haemophilus influenzae causes significant morbidity and mortality in children under five in developing nations.
- * Latin America has implemented Haemophilus influenzae type b (Hib) conjugate vaccines and antimicrobial susceptibility surveillance.
- * Antimicrobial resistance patterns are crucial for guiding effective treatment strategies.
Purpose of the Study:
- * To systematically review and pool data on Haemophilus influenzae antimicrobial resistance in Latin America.
- * To analyze resistance trends over a 10-year period (1990-2000) across 15 Latin American countries.
- * To provide insights into the evolving antimicrobial resistance landscape post-Hib vaccination.
Main Methods:
- * Systematic review and pooled analysis of published reports.
- * Inclusion of data from 15 Latin American countries spanning 1990-2000.
- * Analysis of antimicrobial resistance in both invasive and noninvasive Haemophilus influenzae isolates.
Main Results:
- * Beta-lactamase production was higher in invasive (21.4%) vs. noninvasive (14.5%) isolates.
- * Ampicillin resistance was prevalent in invasive (21.9%) and noninvasive (17.2%) strains.
- * Trimethoprim-sulfamethoxazole (TMP-SMX) resistance was significantly higher in noninvasive (41.9%) vs. invasive (26.9%) isolates, with increasing rates in Brazil.
Conclusions:
- * TMP-SMX resistance is more common in noninvasive isolates and shows an increasing trend in some regions.
- * Post-Hib vaccination, an increase in nontypeable H. influenzae infections is anticipated.
- * Continuous monitoring of H. influenzae antimicrobial resistance is essential for effective clinical management in Latin America.
Abstract:
Haemophilus influenzae is a relevant cause of morbidity and mortality among children under 5 years of age in the developing world. In Latin America, H. influenzae type b (Hib) conjugate vaccine and surveillance of H. influenzae antimicrobial susceptibility have been implemented in recent years. We have undertaken a systematic review and a pooled analysis on H. influenzae antimicrobial resistance, including reports of 15 Latin America countries over a 10-year period (1990-2000). We have found that 450 (21.4%) of 2,100 invasive isolates were beta-lactamase producers compared to 145 (14.5%) of 998 isolates of noninvasive isolates (p < 0.05). Ampicillin resistance was detected among 783 (21.9%) of 3,577 invasive isolates compared to 111 (17.2%) of 646 noninvasive strains (p < 0.05). In contrast, 568 (41.9%) of 1,355 noninvasive strains were trimethoprim-sulfamethoxazole (TMP-SMX) resistance against 241 (26.9%) of 897 invasive ones (p < 0.05). Therefore, TMP-SMX resistance was more common in nonsterile fluids than in sterile fluids. Over time, rates of beta-lactamase-producing strains were stable in Brazil and Mexico, whereas rates of TMP-SMX resistance were increasing in Brazil. It is predictable that following the Hib immunization, Latin America countries will be faced with increased nontypeable H. influenzae infection. Although standing by the nontypeable H. influenzae vaccine, in this novel epidemiological scenario of post-Hib vaccination in Latin America settings there is a need to improve H. influenzae resistance monitoring to guide clinicians to choose efficacious antimicrobial therapy.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Influenza
Clinical Significance of Antibiotic Resistance

